Pfizer Inc. 2022-05-25 Health serious FDA
Health · FDA · Recall #FDA-D-0872-2022
Accupril (Quinapril HCl Tablets) 10 mg, 90 Tablets Rx only NDC 0071-0530-23 Distributed… Recall
Issued May 25, 2022 · Pfizer Inc.
In May 2022, Pfizer Inc. recalled the Accupril (Quinapril HCl Tablets) 10 mg, 90 Tablets Rx only NDC 0071-0530-23 Distributed…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.
What you should do
- 1 Stop using Accupril (Quinapril HCl Tablets) 10 mg, 90 Tablets Rx only NDC 0071-0530-23 Distributed… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Pfizer Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Pfizer Inc.
- Category
- Health
- Recall date
- May 25, 2022
- Units affected
- Not reported
- Sold at
- Nationwide and Puerto Rico
- Recall number
- FDA-D-0872-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Pfizer Inc. has 13 recalls in our database, including 5 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.